AKEBIA THERAPEUTICS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- AKEBIA THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2014-12-31 was $83.00K.
- AKEBIA THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2014-09-30 was $58.00K.
- AKEBIA THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2014 was $162.00K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2014-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $162.00K 10-K · filed 2017-03-06 |
| 2014-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |